Production (Stage)
BioXcel Therapeutics, Inc.
BTAI
$1.39
$0.021.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.01M | 29.85M | 40.39M | 56.27M | 74.14M |
| Total Receivables | -- | 131.00K | 3.00K | 812.00K | 378.00K |
| Inventory | 642.00K | 679.00K | 1.53M | 2.68M | 2.44M |
| Prepaid Expenses | 4.74M | 5.29M | 4.48M | 2.78M | 2.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.39M | 1.44M | 1.40M | 1.64M | 1.86M |
| Total Current Assets | 37.78M | 37.39M | 47.79M | 64.18M | 80.92M |
|
|
|||||
| Total Current Assets | 37.78M | 37.39M | 47.79M | 64.18M | 80.92M |
| Net Property, Plant & Equipment | 702.00K | 857.00K | 1.01M | 1.17M | 1.32M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 87.00K | 87.00K | 87.00K | 87.00K | 87.00K |
| Total Assets | 38.57M | 38.34M | 48.89M | 65.44M | 82.32M |
|
|
|||||
| Total Accounts Payable | 15.45M | 15.99M | 14.89M | 13.26M | 17.22M |
| Total Accrued Expenses | 3.79M | 5.78M | 8.57M | 13.49M | 13.71M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.96M | 374.00K | 368.00K | 361.00K | 353.00K |
| Total Finance Division Other Current Liabilities | 345.00K | 91.00K | 1.73M | 177.00K | 201.00K |
| Total Other Current Liabilities | 345.00K | 91.00K | 1.73M | 177.00K | 201.00K |
| Total Current Liabilities | 25.55M | 22.23M | 25.56M | 27.29M | 31.48M |
|
|
|||||
| Total Current Liabilities | 25.55M | 22.23M | 25.56M | 27.29M | 31.48M |
| Long-Term Debt | 99.92M | 102.51M | 104.44M | 103.01M | 101.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 65.00K | 161.00K | 256.00K | 350.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.27M | 6.63M | 4.37M | 9.19M | 21.22M |
| Total Liabilities | 128.74M | 131.44M | 134.53M | 139.74M | 154.69M |
|
|
|||||
| Common Stock & APIC | 567.28M | 557.10M | 553.71M | 551.39M | 545.03M |
| Retained Earnings | -657.45M | -650.20M | -639.34M | -625.69M | -617.39M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -90.17M | -93.10M | -85.63M | -74.30M | -72.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -90.17M | -93.10M | -85.63M | -74.30M | -72.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -90.17M | -93.10M | -85.63M | -74.30M | -72.36M |
|
|
|||||